- Home
- AGNC vs LNTH Comparison
AGNC vs LNTH Comparison
Compare AGNC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGNC
- LNTH
- Stock Information
- Founded
- AGNC 2008
- LNTH 1956
- Country
- AGNC United States
- LNTH United States
- Employees
- AGNC N/A
- LNTH N/A
- Industry
- AGNC Real Estate Investment Trusts
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AGNC Real Estate
- LNTH Health Care
- Exchange
- AGNC Nasdaq
- LNTH Nasdaq
- Market Cap
- AGNC 9.0B
- LNTH 7.5B
- IPO Year
- AGNC 2008
- LNTH 2015
- Fundamental
- Price
- AGNC $8.83
- LNTH $73.86
- Analyst Decision
- AGNC Buy
- LNTH Strong Buy
- Analyst Count
- AGNC 11
- LNTH 5
- Target Price
- AGNC $9.88
- LNTH $133.80
- AVG Volume (30 Days)
- AGNC 29.5M
- LNTH 1.5M
- Earning Date
- AGNC 04-21-2025
- LNTH 05-07-2025
- Dividend Yield
- AGNC 16.31%
- LNTH N/A
- EPS Growth
- AGNC N/A
- LNTH N/A
- EPS
- AGNC 0.40
- LNTH 3.53
- Revenue
- AGNC $584,000,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- AGNC $39.36
- LNTH $4.63
- Revenue Next Year
- AGNC $22.20
- LNTH $9.35
- P/E Ratio
- AGNC $22.22
- LNTH $20.92
- Revenue Growth
- AGNC N/A
- LNTH 12.53
- 52 Week Low
- AGNC $7.85
- LNTH $73.11
- 52 Week High
- AGNC $10.85
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- AGNC 46.21
- LNTH 26.09
- Support Level
- AGNC $8.65
- LNTH $73.11
- Resistance Level
- AGNC $9.26
- LNTH $81.50
- Average True Range (ATR)
- AGNC 0.18
- LNTH 3.44
- MACD
- AGNC 0.01
- LNTH -1.23
- Stochastic Oscillator
- AGNC 34.46
- LNTH 2.10
About AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.